Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Klein

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Atherosclerosis|October 24, 2007
Intermittent claudication in the Erfurt Male Cohort (ERFORT) Study: its determinants and the impact on mortality. A population-based prospective cohort study with 30 years of follow-upBarbara Kollerits, Joachim Heinrich, Michaela Pichler, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Synthesis, SAR, and antitumor properties of diamino-C,N-diarylpyrimidine positional isomers: inhibitors of lysophosphatidic acid acyltransferase-betaBaoqing Gong, Feng Hong, Cory Kohm, et al.
Atherosclerosis|July 25, 2013
The association of relative telomere length with symptomatic peripheral arterial disease: results from the CAVASIC studyJulia Raschenberger, Barbara Kollerits, Angelika Hammerer-Lercher, et al.
International Journal of Pharmaceutics|September 1, 2005
Application of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cellsFerry J Verbaan, Peter Klein Klouwenberg, Jan Hein van Steenis, et al.
Atherosclerosis|February 16, 2015
Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication - results from the CAVASIC StudyBarbara Rantner, Johannes Pohlhammer, Marietta Stadler, et al.
Atherosclerosis|December 3, 2014
High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC StudyJohannes Pohlhammer, Florian Kronenberg, Barbara Rantner, et al.
Expert Opinion on Therapeutic Targets|September 23, 2003
Lysophosphatidic acid acyltransferase-beta: a novel target for induction of tumour cell apoptosisLynn Bonham, David W Leung, Thayer White, et al.
Scientific Reports|April 4, 2017
The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC StudyBarbara Rantner, Barbara Kollerits, Johannes Pohlhammer, et al.
The Journal of Biological Chemistry|June 25, 2004
Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activityRong-Jun Guo, Edward Huang, Toshihiko Ezaki, et al.
International Journal of Healthcare|November 10, 2018
Patient Participation in the Development of a Customized M-Health Intervention to Improve Medication Adherence in Poorly Adherent Individuals with Bipolar Disorder (BD) and Hypertension (HTN)Carol Blixen, Martha Sajatovic, David J Moore, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Atherosclerosis|October 24, 2007
Intermittent claudication in the Erfurt Male Cohort (ERFORT) Study: its determinants and the impact on mortality. A population-based prospective cohort study with 30 years of follow-upBarbara Kollerits, Joachim Heinrich, Michaela Pichler, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Synthesis, SAR, and antitumor properties of diamino-C,N-diarylpyrimidine positional isomers: inhibitors of lysophosphatidic acid acyltransferase-betaBaoqing Gong, Feng Hong, Cory Kohm, et al.
Atherosclerosis|July 25, 2013
The association of relative telomere length with symptomatic peripheral arterial disease: results from the CAVASIC studyJulia Raschenberger, Barbara Kollerits, Angelika Hammerer-Lercher, et al.
International Journal of Pharmaceutics|September 1, 2005
Application of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cellsFerry J Verbaan, Peter Klein Klouwenberg, Jan Hein van Steenis, et al.
Atherosclerosis|February 16, 2015
Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication - results from the CAVASIC StudyBarbara Rantner, Johannes Pohlhammer, Marietta Stadler, et al.
Atherosclerosis|December 3, 2014
High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC StudyJohannes Pohlhammer, Florian Kronenberg, Barbara Rantner, et al.
Expert Opinion on Therapeutic Targets|September 23, 2003
Lysophosphatidic acid acyltransferase-beta: a novel target for induction of tumour cell apoptosisLynn Bonham, David W Leung, Thayer White, et al.
Scientific Reports|April 4, 2017
The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC StudyBarbara Rantner, Barbara Kollerits, Johannes Pohlhammer, et al.
The Journal of Biological Chemistry|June 25, 2004
Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activityRong-Jun Guo, Edward Huang, Toshihiko Ezaki, et al.
International Journal of Healthcare|November 10, 2018
Patient Participation in the Development of a Customized M-Health Intervention to Improve Medication Adherence in Poorly Adherent Individuals with Bipolar Disorder (BD) and Hypertension (HTN)Carol Blixen, Martha Sajatovic, David J Moore, et al.
Pageof 14